176 related articles for article (PubMed ID: 18715886)
1. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
Lee YM; Choi WH; Kim YB; Ha CS; Song CW; Lee M; Joo CW; Hong Y; Ho SH; Kim S; Kim JM; Koh WS
Hum Exp Toxicol; 2008 May; 27(5):401-7. PubMed ID: 18715886
[TBL] [Abstract][Full Text] [Related]
2. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
3. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
Nunoi H; Ishibashi F
Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
[TBL] [Abstract][Full Text] [Related]
5. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
Nunoi H; Ishibashi F
Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
[TBL] [Abstract][Full Text] [Related]
6. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
[TBL] [Abstract][Full Text] [Related]
7. Stable long-term gene correction with low-dose radiation conditioning in murine X-linked chronic granulomatous disease.
Goebel WS; Pech NK; Dinauer MC
Blood Cells Mol Dis; 2004; 33(3):365-71. PubMed ID: 15528159
[TBL] [Abstract][Full Text] [Related]
8. Progress in gene therapy for chronic granulomatous disease.
Malech HL
J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
[TBL] [Abstract][Full Text] [Related]
9. Progress toward effective gene therapy for chronic granulomatous disease.
Malech HL; Choi U; Brenner S
Jpn J Infect Dis; 2004 Oct; 57(5):S27-8. PubMed ID: 15507764
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for chronic granulomatous disease.
Kang EM; Malech HL
Methods Enzymol; 2012; 507():125-54. PubMed ID: 22365772
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
12. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
Ott MG; Schmidt M; Schwarzwaelder K; Stein S; Siler U; Koehl U; Glimm H; Kühlcke K; Schilz A; Kunkel H; Naundorf S; Brinkmann A; Deichmann A; Fischer M; Ball C; Pilz I; Dunbar C; Du Y; Jenkins NA; Copeland NG; Lüthi U; Hassan M; Thrasher AJ; Hoelzer D; von Kalle C; Seger R; Grez M
Nat Med; 2006 Apr; 12(4):401-9. PubMed ID: 16582916
[TBL] [Abstract][Full Text] [Related]
13. Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors.
Chatziandreou I; Siapati EK; Vassilopoulos G
Exp Hematol; 2011 Jun; 39(6):643-52. PubMed ID: 21426924
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
15. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for chronic granulomatous disease.
Kume A; Dinauer MC
J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for chronic granulomatous disease.
Stein S; Siler U; Ott MG; Seger R; Grez M
Curr Opin Mol Ther; 2006 Oct; 8(5):415-22. PubMed ID: 17078383
[TBL] [Abstract][Full Text] [Related]
18. Hematological toxicity of repeated injections of (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea.
Rebischung JL; Gougeon MD; Mori KJ; Lemaigre G; Mathé G; Jasmin C
Cancer Res; 1984 Feb; 44(2):503-6. PubMed ID: 6692356
[TBL] [Abstract][Full Text] [Related]
19. Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease.
Goebel WS; Mark LA; Billings SD; Meyers JL; Pech N; Travers JB; Dinauer MC
J Invest Dermatol; 2005 Oct; 125(4):705-10. PubMed ID: 16185269
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.
Sadat MA; Dirscherl S; Sastry L; Dantzer J; Pech N; Griffin S; Hawkins T; Zhao Y; Barese CN; Cross S; Orazi A; An C; Goebel WS; Yoder MC; Li X; Grez M; Cornetta K; Mooney SD; Dinauer MC
Gene Ther; 2009 Dec; 16(12):1452-64. PubMed ID: 19657370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]